Testing effectiveness (Phase 2)Study completedNCT00727506
What this trial is testing
BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
Who this might be right for
Glioma
Boehringer Ingelheim 151